SlideShare a Scribd company logo
1 of 11
Analytical Control Strategy – Part-4
How the modern concept of a lifecycle model can be applied to analytical procedures.
Chandra Prakash Singh
STAGE 2: QUALIFICATION
The second stage in the lifecycle approach to validation of analytical procedures involves confirming (or qualifying) that
the procedure meets the requirements of the ATP (typically, the accuracy and precision of the reportable value), in the
facility where the procedure will be routinely operated.
Many of the important analytical characteristics, such as linearity, range, specificity, and sensitivity, will have been
evaluated and characterized during stage 1.
This qualification activity takes place once the initial ACS has been defined. The result of the qualification activity may
indicate that the ACS needs to be extended. An example of this could be a change to the replication strategy for samples
and standards.
How the ACS Applies to the Product Lifecycle
Routine Monitoring
The aim of introducing a system for routine monitoring of procedure performance is to ensure that the analytical procedure is
continuously producing reportable results that are fit for intended use.
An analytical procedure can be considered fit for purpose when the requirements of the ATP are met.
A routine monitoring program therefore needs to be designed to:
 Continually ensure that the reportable results produced by the procedure are fit for purpose.
 Provide an early indication of potential procedure performance issues or adverse trends.
 Ensure that any new understanding of the impact of variables on procedure performance is addressed in an updated ACS.
STAGE 3: CONTINUAL VERIFICATION
Once an ACS has been established and qualified as part of the analytical procedure, it is important that the performance of
the procedure is maintained throughout the lifecycle. It is important therefore to have mechanisms for:
 Routine monitoring of the performance of the analytical procedure.
 Controlling changes made to the analytical procedure.
If the procedure is found to be producing inconsistent reportable values that do not meet the performance requirements
defined in the ATP, or the root cause of performance issues identified from lab investigations indicates that a critical
variable has not been identified or adequately controlled, the QRM process ACS should be reviewed and updated to reflect
this new information.
 The system suitability checks are useful in establishing that a method is performing satisfactorily at time of use, having a
mechanism for trending method performance over time is important in order to verify that the key variables impacting a
procedure’s performance are adequately understood and controlled.
 A program based on statistical process control techniques is useful in order to trend the key indicators of procedure
performance.
 Trend plots of critical procedure performance indicators - such as resolution values, RSDs from system precision checks,
results from routine testing, control or stability samples, or OOS or out-of-trend (OOT) investigations - can be established.
Change Control
There are many drivers that may result in a change in the procedure. These include:
 Changes driven by the need to address new requirements for data quality (e.g., the tightening of specification limits or the
need to control potential impurities from new suppliers of materials).
 Changes made to improve the quality of the data produced (e.g., where the measurement uncertainty is no longer
acceptable or where new critical variables are identified).
 Changes that allow the data to be generated more quickly, more cost effectively, or by using more sustainable methods.
 A system of change control should be established and should provide the means for ensuring that all changes are recorded,
evaluated, and approved prior to being implemented. In order to assess the impact of a change, it is important to first
understand the requirements of the data.
 The ATP that defines the maximum acceptable TMU should be used as the basis against which to assess the change.
 The change control system should ensure that any changes are re-qualified as being able to meet the TMU requirements in
the ATP, that work is completed, and that supporting documentation is updated and approved before the procedure is
returned or introduced to routine use.
Depending on the degree of change, the actions required to qualify the change will be different. Some examples are as follows:
1. A change in a method variable to a value that is within a range that was previously proven to produce fit-for purpose data
(e.g., changing an HPLC flow rate from 1.0 mL/min to 1.5 mL/min for an analytical procedure where a range of 1–2 mL/min
was qualified during the method design stage). In this case, no additional experimentation is required to qualify the change.
2. Where the change is simply adding additional controls to an existing procedure (e.g., adding extra impurities to a test mix
to help with peak identification). Again, this would not typically require any experimentation to qualify the change.
3. A change in a procedure variable to a value outside the range that was previously proven to produce fit-for purpose data
(e.g., changing a flow rate to 0.8 mL/min for the method used in the previous example). Changing to a method noise variable
(e.g., a critical reagent source) would require a risk assessment. This should consider which procedure performance
characteristics may be impacted by the change and then should perform an appropriate method performance verification
study to confirm that the change does not impact the method’s ability to meet the ATP.
4. A change to a new procedure/technique would require performance of appropriate development, understanding, and
qualification activities to demonstrate conformance of the new procedure to the ATP.
5. A change impacting the ATP (e.g., a specification limit change or the need to apply the procedure to measure levels of
analytes not considered in the original ATP) would require an update to the ATP and a review of the existing procedure
qualification data to determine whether the procedure will still meet the requirements of the new ATP. If not, a new or
optimized analytical procedure or technology will be required and actions similar to those for example d. above would be
required.
6. Sometimes it may be necessary to use the method in a new location (i.e., analytical transfer or implementation of
compendial procedures). This type of change should be treated similarly to example 3 above. In this case, however, it is
particularly important that effective knowledge transfer takes place between the established and new locations.
 The level of qualification required to confirm a changed analytical procedure is producing fit for purpose data will depend
on an assessment of the risk associated with the change.
 It is recommended that, for all changes, a risk assessment should be carried out to determine the appropriate level of (re-)
qualification activities required.
 The aim of the (re-)qualification exercise is to provide confidence that the modified method will produce results that meet
the criteria defined in the ATP.
 This may be assessed by considering the risk that the change in the method will have on the accuracy and the precision of
the reportable result.
 Risk assessment tools can be used to provide guidance on what actions are appropriate to verify that the method is
performing as required.
ACS for Different Sites
 When an analytical procedure is going to be used at a new site, the laboratory will have to demonstrate that it can execute the procedure
in a fit-for-purpose manner.
 Thus, the lab will have to show that when the analytical procedure is executed, the reportable result will meet the criteria established in
the ATP.
 The preparation for the implementation of the new procedure will differ depending on how much knowledge is available - for example,
an inhouse method where the development findings, risk assessment conclusions, and subsequently established ACS are all known,
compared with a compendial method where knowledge may not be available.
 In the latter case, some of the QRM steps need to be verified, and as a result the ACS may need to be expanded. For example, additional
environmental controls such as impact of exposure to light, temperature, and humidity; sample solution stability; or establishment of the
site-specific replicate strategy need to be developed.
 The extent of the additional development/verification work will depend on how much knowledge is available to the receiving laboratory
at the time of the qualification.
 Once the verification is complete, the new site will develop a qualification protocol or execute the existing qualification protocol to
demonstrate that it is capable of generating a reportable result that meets the criteria established in the ATP, thus validating the original
or the expanded ACS.
 After implementation, the new site should develop and implement the Stage 3: Continual verification procedure.
 Adopting a systematic approach to developing an ACS, in combination with the ATP (which is the driver for the
development of the control strategy), will improve the performance of an analytical procedure.
 The use of KM and QRM tools will ensure that all work carried out during method design and development (stage 1) is
value added, and should ensure a successful qualification exercise at stage 2.
 Maintaining the control strategy when the method is in routine use (stage 3) through continually monitoring the
performance of the procedure and applying good change control practices will ensure that the procedure maintains its “in-
control” status.
ACS
?
Thanks

More Related Content

What's hot

Introduction to Analytical Method Development and Validation for Therapeutic ...
Introduction to Analytical Method Development and Validation for Therapeutic ...Introduction to Analytical Method Development and Validation for Therapeutic ...
Introduction to Analytical Method Development and Validation for Therapeutic ...PeteDeOlympio
 
Internal quality control
Internal quality controlInternal quality control
Internal quality controlSyed Basheer
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validationSHIVANEE VYAS
 
Data Analysis Of An Analytical Method Transfer To
Data Analysis Of An Analytical Method Transfer ToData Analysis Of An Analytical Method Transfer To
Data Analysis Of An Analytical Method Transfer ToDwayne Neal
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validationSai Praveen Reddy
 
Laboratory quality management system
Laboratory quality management systemLaboratory quality management system
Laboratory quality management systemselinasimpson0801
 
Method Validation: What Are Its Key Parameters
Method Validation:What Are Its Key ParametersMethod Validation:What Are Its Key Parameters
Method Validation: What Are Its Key Parameterscomplianceonline123
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validationArti Thakkar
 
Analytical method Validation
Analytical method ValidationAnalytical method Validation
Analytical method Validationprashik shimpi
 
Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13
Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13
Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13Stephan O. Krause, PhD
 
Chapter 12
Chapter 12Chapter 12
Chapter 12ECRD IN
 
Quality assurance and quality control
Quality assurance and quality controlQuality assurance and quality control
Quality assurance and quality controlECRD2015
 
Method validation
Method validationMethod validation
Method validationDrHinal
 
validation of analytical procedure USFDA Guidline
validation of analytical procedure USFDA Guidlinevalidation of analytical procedure USFDA Guidline
validation of analytical procedure USFDA GuidlineArchana Chavhan
 
Analytical Method Validation as per ICH vs USP
Analytical Method Validation as per ICH vs USPAnalytical Method Validation as per ICH vs USP
Analytical Method Validation as per ICH vs USPKushal Shah
 
Variability of clinical chemistry laboratory results
Variability of clinical  chemistry laboratory resultsVariability of clinical  chemistry laboratory results
Variability of clinical chemistry laboratory resultsAdetokunboAjala
 

What's hot (20)

Life cycle of analytical method
Life cycle of analytical methodLife cycle of analytical method
Life cycle of analytical method
 
Analytical method validation
Analytical method validation Analytical method validation
Analytical method validation
 
Introduction to Analytical Method Development and Validation for Therapeutic ...
Introduction to Analytical Method Development and Validation for Therapeutic ...Introduction to Analytical Method Development and Validation for Therapeutic ...
Introduction to Analytical Method Development and Validation for Therapeutic ...
 
Internal quality control
Internal quality controlInternal quality control
Internal quality control
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 
Data Analysis Of An Analytical Method Transfer To
Data Analysis Of An Analytical Method Transfer ToData Analysis Of An Analytical Method Transfer To
Data Analysis Of An Analytical Method Transfer To
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 
Laboratory quality management system
Laboratory quality management systemLaboratory quality management system
Laboratory quality management system
 
Analytical validation
Analytical validationAnalytical validation
Analytical validation
 
Method Validation: What Are Its Key Parameters
Method Validation:What Are Its Key ParametersMethod Validation:What Are Its Key Parameters
Method Validation: What Are Its Key Parameters
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 
Analytical method Validation
Analytical method ValidationAnalytical method Validation
Analytical method Validation
 
analytical method validation
analytical method validationanalytical method validation
analytical method validation
 
Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13
Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13
Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13
 
Chapter 12
Chapter 12Chapter 12
Chapter 12
 
Quality assurance and quality control
Quality assurance and quality controlQuality assurance and quality control
Quality assurance and quality control
 
Method validation
Method validationMethod validation
Method validation
 
validation of analytical procedure USFDA Guidline
validation of analytical procedure USFDA Guidlinevalidation of analytical procedure USFDA Guidline
validation of analytical procedure USFDA Guidline
 
Analytical Method Validation as per ICH vs USP
Analytical Method Validation as per ICH vs USPAnalytical Method Validation as per ICH vs USP
Analytical Method Validation as per ICH vs USP
 
Variability of clinical chemistry laboratory results
Variability of clinical  chemistry laboratory resultsVariability of clinical  chemistry laboratory results
Variability of clinical chemistry laboratory results
 

Similar to Analytical control strategy 4

An efficient analytical development strategy for rapid development of biophar...
An efficient analytical development strategy for rapid development of biophar...An efficient analytical development strategy for rapid development of biophar...
An efficient analytical development strategy for rapid development of biophar...ManivannanKathirvel1
 
An Efficient Analytical Development Strategy for Rapid Development of Biophar...
An Efficient Analytical Development Strategy for Rapid Development of Biophar...An Efficient Analytical Development Strategy for Rapid Development of Biophar...
An Efficient Analytical Development Strategy for Rapid Development of Biophar...ManivannanKathirvel1
 
Pharmaceutical validation QA I Year.pptx
Pharmaceutical validation QA I Year.pptxPharmaceutical validation QA I Year.pptx
Pharmaceutical validation QA I Year.pptxmanoharkasde123
 
PHARMACEUTICAL VALIDATION
PHARMACEUTICAL VALIDATIONPHARMACEUTICAL VALIDATION
PHARMACEUTICAL VALIDATIONJayeshRajput7
 
bio statistical tools of process validation
bio statistical tools of process validationbio statistical tools of process validation
bio statistical tools of process validationmounika chowdary
 
Process validation fda
Process validation fdaProcess validation fda
Process validation fdaFasika Mekete
 
TOTAL QUALITY MANAGEMENT.pptx
TOTAL QUALITY MANAGEMENT.pptxTOTAL QUALITY MANAGEMENT.pptx
TOTAL QUALITY MANAGEMENT.pptxDr. Jagroop Singh
 
DI workshop.pdf
DI workshop.pdfDI workshop.pdf
DI workshop.pdfagothoskar
 
090528 Miller Process Forensics Talk @ Asq
090528 Miller Process Forensics Talk @ Asq090528 Miller Process Forensics Talk @ Asq
090528 Miller Process Forensics Talk @ Asqrwmill9716
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validationTausif Momin
 
Seminar on validation by ranjeet singh
Seminar on validation by ranjeet singhSeminar on validation by ranjeet singh
Seminar on validation by ranjeet singhRanjeet Singh
 
Internal Quality Control Lecture MD General 2014 Course, Clin Path Ain Shams ...
Internal Quality Control Lecture MD General 2014 Course, Clin Path Ain Shams ...Internal Quality Control Lecture MD General 2014 Course, Clin Path Ain Shams ...
Internal Quality Control Lecture MD General 2014 Course, Clin Path Ain Shams ...Adel Elazab Elged
 
Analytical Method Development
Analytical Method DevelopmentAnalytical Method Development
Analytical Method DevelopmentBijesh Verma
 

Similar to Analytical control strategy 4 (20)

Chapter 5.ppt
Chapter 5.pptChapter 5.ppt
Chapter 5.ppt
 
An efficient analytical development strategy for rapid development of biophar...
An efficient analytical development strategy for rapid development of biophar...An efficient analytical development strategy for rapid development of biophar...
An efficient analytical development strategy for rapid development of biophar...
 
An Efficient Analytical Development Strategy for Rapid Development of Biophar...
An Efficient Analytical Development Strategy for Rapid Development of Biophar...An Efficient Analytical Development Strategy for Rapid Development of Biophar...
An Efficient Analytical Development Strategy for Rapid Development of Biophar...
 
Pqs220610.Ppt
Pqs220610.PptPqs220610.Ppt
Pqs220610.Ppt
 
Pqs220610.ppt
Pqs220610.pptPqs220610.ppt
Pqs220610.ppt
 
Pqs220610.Ppt
Pqs220610.PptPqs220610.Ppt
Pqs220610.Ppt
 
Pharmaceutical validation QA I Year.pptx
Pharmaceutical validation QA I Year.pptxPharmaceutical validation QA I Year.pptx
Pharmaceutical validation QA I Year.pptx
 
PHARMACEUTICAL VALIDATION
PHARMACEUTICAL VALIDATIONPHARMACEUTICAL VALIDATION
PHARMACEUTICAL VALIDATION
 
change control
change controlchange control
change control
 
bio statistical tools of process validation
bio statistical tools of process validationbio statistical tools of process validation
bio statistical tools of process validation
 
Process validation fda
Process validation fdaProcess validation fda
Process validation fda
 
TOTAL QUALITY MANAGEMENT.pptx
TOTAL QUALITY MANAGEMENT.pptxTOTAL QUALITY MANAGEMENT.pptx
TOTAL QUALITY MANAGEMENT.pptx
 
DI workshop.pdf
DI workshop.pdfDI workshop.pdf
DI workshop.pdf
 
Quality control
Quality controlQuality control
Quality control
 
090528 Miller Process Forensics Talk @ Asq
090528 Miller Process Forensics Talk @ Asq090528 Miller Process Forensics Talk @ Asq
090528 Miller Process Forensics Talk @ Asq
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 
Process validation
Process validationProcess validation
Process validation
 
Seminar on validation by ranjeet singh
Seminar on validation by ranjeet singhSeminar on validation by ranjeet singh
Seminar on validation by ranjeet singh
 
Internal Quality Control Lecture MD General 2014 Course, Clin Path Ain Shams ...
Internal Quality Control Lecture MD General 2014 Course, Clin Path Ain Shams ...Internal Quality Control Lecture MD General 2014 Course, Clin Path Ain Shams ...
Internal Quality Control Lecture MD General 2014 Course, Clin Path Ain Shams ...
 
Analytical Method Development
Analytical Method DevelopmentAnalytical Method Development
Analytical Method Development
 

More from Chandra Prakash Singh

VALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and Definitions
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and DefinitionsVALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and Definitions
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and DefinitionsChandra Prakash Singh
 
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2)
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2)VALIDATION OF ANALYTICAL PROCEDURES Q2(R2)
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2)Chandra Prakash Singh
 
NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)
NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)
NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)Chandra Prakash Singh
 
Currently Identified Risk Factors for Presence of Nitrosamines.pptx
Currently Identified Risk Factors for Presence of Nitrosamines.pptxCurrently Identified Risk Factors for Presence of Nitrosamines.pptx
Currently Identified Risk Factors for Presence of Nitrosamines.pptxChandra Prakash Singh
 
X-Rays The basic understanding of XRD analysis
X-Rays The basic understanding of XRD analysisX-Rays The basic understanding of XRD analysis
X-Rays The basic understanding of XRD analysisChandra Prakash Singh
 
X-RAY POWDER DIFFRACTION (XRPD).pptx
X-RAY POWDER DIFFRACTION (XRPD).pptxX-RAY POWDER DIFFRACTION (XRPD).pptx
X-RAY POWDER DIFFRACTION (XRPD).pptxChandra Prakash Singh
 
LCMS - Ion Optics Path and Parameters.pptx
LCMS - Ion Optics Path and Parameters.pptxLCMS - Ion Optics Path and Parameters.pptx
LCMS - Ion Optics Path and Parameters.pptxChandra Prakash Singh
 
Acid base equilibria and reversed phase retention
Acid base equilibria and reversed phase retentionAcid base equilibria and reversed phase retention
Acid base equilibria and reversed phase retentionChandra Prakash Singh
 
Decision between homoscedasticity or heteroscedasticity for linearity data (C...
Decision between homoscedasticity or heteroscedasticity for linearity data (C...Decision between homoscedasticity or heteroscedasticity for linearity data (C...
Decision between homoscedasticity or heteroscedasticity for linearity data (C...Chandra Prakash Singh
 

More from Chandra Prakash Singh (20)

VALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and Definitions
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and DefinitionsVALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and Definitions
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and Definitions
 
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2)
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2)VALIDATION OF ANALYTICAL PROCEDURES Q2(R2)
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2)
 
NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)
NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)
NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)
 
Currently Identified Risk Factors for Presence of Nitrosamines.pptx
Currently Identified Risk Factors for Presence of Nitrosamines.pptxCurrently Identified Risk Factors for Presence of Nitrosamines.pptx
Currently Identified Risk Factors for Presence of Nitrosamines.pptx
 
LCMS_BASIC UNDERSTANDING.pdf
LCMS_BASIC UNDERSTANDING.pdfLCMS_BASIC UNDERSTANDING.pdf
LCMS_BASIC UNDERSTANDING.pdf
 
LCMS Type of Scan.pdf
LCMS Type of Scan.pdfLCMS Type of Scan.pdf
LCMS Type of Scan.pdf
 
X-Rays The basic understanding of XRD analysis
X-Rays The basic understanding of XRD analysisX-Rays The basic understanding of XRD analysis
X-Rays The basic understanding of XRD analysis
 
X-RAY POWDER DIFFRACTION (XRPD).pptx
X-RAY POWDER DIFFRACTION (XRPD).pptxX-RAY POWDER DIFFRACTION (XRPD).pptx
X-RAY POWDER DIFFRACTION (XRPD).pptx
 
Triplus500 HS working.pptx
Triplus500 HS working.pptxTriplus500 HS working.pptx
Triplus500 HS working.pptx
 
LCMS - Ion Optics Path and Parameters.pptx
LCMS - Ion Optics Path and Parameters.pptxLCMS - Ion Optics Path and Parameters.pptx
LCMS - Ion Optics Path and Parameters.pptx
 
Diverter Valve.pptx
Diverter Valve.pptxDiverter Valve.pptx
Diverter Valve.pptx
 
LCMS_interface.pptx
LCMS_interface.pptxLCMS_interface.pptx
LCMS_interface.pptx
 
FID detector
FID detectorFID detector
FID detector
 
HPLC Column
HPLC ColumnHPLC Column
HPLC Column
 
Acid base equilibria and reversed phase retention
Acid base equilibria and reversed phase retentionAcid base equilibria and reversed phase retention
Acid base equilibria and reversed phase retention
 
System suitability
System suitabilitySystem suitability
System suitability
 
Linearity cochran test
Linearity cochran testLinearity cochran test
Linearity cochran test
 
Decision between homoscedasticity or heteroscedasticity for linearity data (C...
Decision between homoscedasticity or heteroscedasticity for linearity data (C...Decision between homoscedasticity or heteroscedasticity for linearity data (C...
Decision between homoscedasticity or heteroscedasticity for linearity data (C...
 
Analytical balance
Analytical balanceAnalytical balance
Analytical balance
 
cpsingh_jubl
cpsingh_jublcpsingh_jubl
cpsingh_jubl
 

Recently uploaded

ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...JojoEDelaCruz
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONHumphrey A Beña
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxAnupkumar Sharma
 
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptxMusic 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptxleah joy valeriano
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4JOYLYNSAMANIEGO
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management SystemChristalin Nelson
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfPatidar M
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxAshokKarra1
 
Food processing presentation for bsc agriculture hons
Food processing presentation for bsc agriculture honsFood processing presentation for bsc agriculture hons
Food processing presentation for bsc agriculture honsManeerUddin
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfTechSoup
 
Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)cama23
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxlancelewisportillo
 

Recently uploaded (20)

ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
 
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptxMusic 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management System
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdf
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptx
 
Food processing presentation for bsc agriculture hons
Food processing presentation for bsc agriculture honsFood processing presentation for bsc agriculture hons
Food processing presentation for bsc agriculture hons
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptxFINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
 
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptxYOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
Raw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptxRaw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptx
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
 
Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
 

Analytical control strategy 4

  • 1. Analytical Control Strategy – Part-4 How the modern concept of a lifecycle model can be applied to analytical procedures. Chandra Prakash Singh
  • 2. STAGE 2: QUALIFICATION The second stage in the lifecycle approach to validation of analytical procedures involves confirming (or qualifying) that the procedure meets the requirements of the ATP (typically, the accuracy and precision of the reportable value), in the facility where the procedure will be routinely operated. Many of the important analytical characteristics, such as linearity, range, specificity, and sensitivity, will have been evaluated and characterized during stage 1. This qualification activity takes place once the initial ACS has been defined. The result of the qualification activity may indicate that the ACS needs to be extended. An example of this could be a change to the replication strategy for samples and standards. How the ACS Applies to the Product Lifecycle
  • 3. Routine Monitoring The aim of introducing a system for routine monitoring of procedure performance is to ensure that the analytical procedure is continuously producing reportable results that are fit for intended use. An analytical procedure can be considered fit for purpose when the requirements of the ATP are met. A routine monitoring program therefore needs to be designed to:  Continually ensure that the reportable results produced by the procedure are fit for purpose.  Provide an early indication of potential procedure performance issues or adverse trends.  Ensure that any new understanding of the impact of variables on procedure performance is addressed in an updated ACS. STAGE 3: CONTINUAL VERIFICATION Once an ACS has been established and qualified as part of the analytical procedure, it is important that the performance of the procedure is maintained throughout the lifecycle. It is important therefore to have mechanisms for:  Routine monitoring of the performance of the analytical procedure.  Controlling changes made to the analytical procedure.
  • 4. If the procedure is found to be producing inconsistent reportable values that do not meet the performance requirements defined in the ATP, or the root cause of performance issues identified from lab investigations indicates that a critical variable has not been identified or adequately controlled, the QRM process ACS should be reviewed and updated to reflect this new information.  The system suitability checks are useful in establishing that a method is performing satisfactorily at time of use, having a mechanism for trending method performance over time is important in order to verify that the key variables impacting a procedure’s performance are adequately understood and controlled.  A program based on statistical process control techniques is useful in order to trend the key indicators of procedure performance.  Trend plots of critical procedure performance indicators - such as resolution values, RSDs from system precision checks, results from routine testing, control or stability samples, or OOS or out-of-trend (OOT) investigations - can be established.
  • 5. Change Control There are many drivers that may result in a change in the procedure. These include:  Changes driven by the need to address new requirements for data quality (e.g., the tightening of specification limits or the need to control potential impurities from new suppliers of materials).  Changes made to improve the quality of the data produced (e.g., where the measurement uncertainty is no longer acceptable or where new critical variables are identified).  Changes that allow the data to be generated more quickly, more cost effectively, or by using more sustainable methods.  A system of change control should be established and should provide the means for ensuring that all changes are recorded, evaluated, and approved prior to being implemented. In order to assess the impact of a change, it is important to first understand the requirements of the data.  The ATP that defines the maximum acceptable TMU should be used as the basis against which to assess the change.  The change control system should ensure that any changes are re-qualified as being able to meet the TMU requirements in the ATP, that work is completed, and that supporting documentation is updated and approved before the procedure is returned or introduced to routine use.
  • 6. Depending on the degree of change, the actions required to qualify the change will be different. Some examples are as follows: 1. A change in a method variable to a value that is within a range that was previously proven to produce fit-for purpose data (e.g., changing an HPLC flow rate from 1.0 mL/min to 1.5 mL/min for an analytical procedure where a range of 1–2 mL/min was qualified during the method design stage). In this case, no additional experimentation is required to qualify the change. 2. Where the change is simply adding additional controls to an existing procedure (e.g., adding extra impurities to a test mix to help with peak identification). Again, this would not typically require any experimentation to qualify the change. 3. A change in a procedure variable to a value outside the range that was previously proven to produce fit-for purpose data (e.g., changing a flow rate to 0.8 mL/min for the method used in the previous example). Changing to a method noise variable (e.g., a critical reagent source) would require a risk assessment. This should consider which procedure performance characteristics may be impacted by the change and then should perform an appropriate method performance verification study to confirm that the change does not impact the method’s ability to meet the ATP.
  • 7. 4. A change to a new procedure/technique would require performance of appropriate development, understanding, and qualification activities to demonstrate conformance of the new procedure to the ATP. 5. A change impacting the ATP (e.g., a specification limit change or the need to apply the procedure to measure levels of analytes not considered in the original ATP) would require an update to the ATP and a review of the existing procedure qualification data to determine whether the procedure will still meet the requirements of the new ATP. If not, a new or optimized analytical procedure or technology will be required and actions similar to those for example d. above would be required. 6. Sometimes it may be necessary to use the method in a new location (i.e., analytical transfer or implementation of compendial procedures). This type of change should be treated similarly to example 3 above. In this case, however, it is particularly important that effective knowledge transfer takes place between the established and new locations.
  • 8.  The level of qualification required to confirm a changed analytical procedure is producing fit for purpose data will depend on an assessment of the risk associated with the change.  It is recommended that, for all changes, a risk assessment should be carried out to determine the appropriate level of (re-) qualification activities required.  The aim of the (re-)qualification exercise is to provide confidence that the modified method will produce results that meet the criteria defined in the ATP.  This may be assessed by considering the risk that the change in the method will have on the accuracy and the precision of the reportable result.  Risk assessment tools can be used to provide guidance on what actions are appropriate to verify that the method is performing as required.
  • 9. ACS for Different Sites  When an analytical procedure is going to be used at a new site, the laboratory will have to demonstrate that it can execute the procedure in a fit-for-purpose manner.  Thus, the lab will have to show that when the analytical procedure is executed, the reportable result will meet the criteria established in the ATP.  The preparation for the implementation of the new procedure will differ depending on how much knowledge is available - for example, an inhouse method where the development findings, risk assessment conclusions, and subsequently established ACS are all known, compared with a compendial method where knowledge may not be available.  In the latter case, some of the QRM steps need to be verified, and as a result the ACS may need to be expanded. For example, additional environmental controls such as impact of exposure to light, temperature, and humidity; sample solution stability; or establishment of the site-specific replicate strategy need to be developed.  The extent of the additional development/verification work will depend on how much knowledge is available to the receiving laboratory at the time of the qualification.  Once the verification is complete, the new site will develop a qualification protocol or execute the existing qualification protocol to demonstrate that it is capable of generating a reportable result that meets the criteria established in the ATP, thus validating the original or the expanded ACS.  After implementation, the new site should develop and implement the Stage 3: Continual verification procedure.
  • 10.  Adopting a systematic approach to developing an ACS, in combination with the ATP (which is the driver for the development of the control strategy), will improve the performance of an analytical procedure.  The use of KM and QRM tools will ensure that all work carried out during method design and development (stage 1) is value added, and should ensure a successful qualification exercise at stage 2.  Maintaining the control strategy when the method is in routine use (stage 3) through continually monitoring the performance of the procedure and applying good change control practices will ensure that the procedure maintains its “in- control” status. ACS